Omicron News and Research

RSS

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Researchers assessed the duration of SARS-CoV-2 Omicron BA.5 neutralization in SARS-CoV-2 vaccinated persons.

27 Jul 2022

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Scientists have described the prevalence of vaccine breakthrough SARS-CoV-2 infection in South Africa during the period of delta and omicron circulation.

27 Jul 2022

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Researchers report the efficacy and safety of molnupiravir in treating COVID-19.

26 Jul 2022

Three doses of Novavax vaccine effective against Omicron subvariants

Researchers report that Novavax COVID-19 vaccine triggers robust neutralization against SARS-CoV-2 Omicron subvariants.

26 Jul 2022

Study describes county-to-county SARS-CoV-2 transmission in Minnesota

New research has recently described the county-to-county transmission of SARS-CoV-2 in Minnesota.

26 Jul 2022

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

In a new study, researchers developed a maximum likelihood model to capture severe acute respiratory syndrome coronavirus 2 evolutionary dynamics in multiple geographical regions.

26 Jul 2022

BNT162b2 vaccination induces moderate immunity against Omicron variant in children

Researchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron in five to 11-year-old children.

26 Jul 2022

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Researchers explore the impact of differential immune imprinting patterns in individuals vaccinated against COVID-19 with a history of prior infection.

25 Jul 2022

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

Researchers study the functional impact of Omicron mutations.

25 Jul 2022

Quarantine guidance for Omicron infection

The CDC provides updated guidelines on how the U.S. population can protect themselves and others from the SARS-CoV-2 Omicron variant.

25 Jul 2022

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A new study discusses the development of recombinant vesicular stomatitis virus COVID-19 vaccines.

25 Jul 2022

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Researchers discuss the development and efficacy of a bivalent mRNA vaccine against emerging variants such as BA.2.12.1, BA.4, or BA.5.

25 Jul 2022

Why Omicron is more infectious than other SARS-CoV-2 variants

Researchers describe SARS-CoV-2 Omicron mutations and their impact on neutralization and infectivity.

25 Jul 2022

Scientists investigate how interferons interact with SARS-CoV-2 variants

Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19.

25 Jul 2022

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

A new study reported the outcomes of a clinical trial evaluating the oral vaccine candidate against SARS-CoV-2 developed by Vaxart.

25 Jul 2022

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

22 Jul 2022

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Booster vaccination counters the severity of Omicron breakthrough infections

Researchers assessed a panel of seven SARS-CoV-2 vaccines currently available globally and in the United States and immunity acquired through the previous infection against all Omicron subvariants.

21 Jul 2022

Omicron News and Research

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Three doses of Novavax vaccine effective against Omicron subvariants

Study describes county-to-county SARS-CoV-2 transmission in Minnesota

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

BNT162b2 vaccination induces moderate immunity against Omicron variant in children

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity

Quarantine guidance for Omicron infection

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Why Omicron is more infectious than other SARS-CoV-2 variants

Scientists investigate how interferons interact with SARS-CoV-2 variants

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

A different approach to build a more durable, broadly effective COVID-19 vaccine

Booster vaccination counters the severity of Omicron breakthrough infections

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News